The activation of Nrf2 significantly protects against DN via its translocation into the nucleus, where it triggers the modulation of multiple DN biomarkers (collagen IV, laminin, TGF-β1, and fibronectin) (Adelusi et al., 2020). This evidence concerns the gene LAMB2 and liver dysplastic nodule.